Literature DB >> 27363332

Structural differences between amyloid beta oligomers.

Leonid Breydo1, Dmitry Kurouski2, Suhail Rasool3, Saskia Milton3, Jessica W Wu3, Vladimir N Uversky4, Igor K Lednev2, Charles G Glabe5.   

Abstract

In Alzheimer's disease, soluble Aβ oligomers are believed to play important roles in the disease pathogenesis, and their levels correlate with cognitive impairment. We have previously shown that Aβ oligomers can be categorized into multiple structural classes based on their reactivity with conformation-dependent antibodies. In this study, we analyzed the structures of Aβ40 oligomers belonging to two of these classes: fibrillar and prefibrillar oligomers. We found that fibrillar oligomers were similar in structure to fibrils but were less stable towards denaturation while prefibrillar oligomers were found to be partially disordered. These results are consistent with previously proposed structures for both oligomer classes while providing additional structural information.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; Amyloid beta; Oligomers; Protein aggregation

Mesh:

Substances:

Year:  2016        PMID: 27363332     DOI: 10.1016/j.bbrc.2016.06.122

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  A long-lived Aβ oligomer resistant to fibrillization.

Authors:  Mimi Nick; Yibing Wu; Nathan W Schmidt; Stanley B Prusiner; Jan Stöhr; William F DeGrado
Journal:  Biopolymers       Date:  2018-01-10       Impact factor: 2.505

2.  Pre-aggregation kinetics and intermediates of α-synuclein monitored by the ESIPT probe 7MFE.

Authors:  Jonathan A Fauerbach; Thomas M Jovin
Journal:  Eur Biophys J       Date:  2017-12-18       Impact factor: 1.733

Review 3.  High-resolution probing of early events in amyloid-β aggregation related to Alzheimer's disease.

Authors:  Bikash R Sahoo; Sarah J Cox; Ayyalusamy Ramamoorthy
Journal:  Chem Commun (Camb)       Date:  2020-04-17       Impact factor: 6.222

4.  α-Sheet secondary structure in amyloid β-peptide drives aggregation and toxicity in Alzheimer's disease.

Authors:  Dylan Shea; Cheng-Chieh Hsu; Timothy M Bi; Natasha Paranjapye; Matthew Carter Childers; Joshua Cochran; Colson P Tomberlin; Libo Wang; Daniel Paris; Jeffrey Zonderman; Gabriele Varani; Christopher D Link; Mike Mullan; Valerie Daggett
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-19       Impact factor: 11.205

5.  Impact of Electronic Polarization on Preformed, β-Strand Rich Homogenous and Heterogenous Amyloid Oligomers.

Authors:  Kelsie M King; Amanda K Sharp; Darcy S Davidson; Anne M Brown; Justin A Lemkul
Journal:  J Comput Biophys Chem       Date:  2021-12-29

6.  Simulations of cross-amyloid aggregation of amyloid-β and islet amyloid polypeptide fragments.

Authors:  Grant E Kawecki; Kelsie M King; Nicholas A Cramer; David R Bevan; Anne M Brown
Journal:  Biophys J       Date:  2022-05-10       Impact factor: 3.699

7.  Fibrillar and Nonfibrillar Amyloid Beta Structures Drive Two Modes of Membrane-Mediated Toxicity.

Authors:  Crystal M Vander Zanden; Lois Wampler; Isabella Bowers; Erik B Watkins; Jaroslaw Majewski; Eva Y Chi
Journal:  Langmuir       Date:  2019-09-26       Impact factor: 3.882

Review 8.  Half a century of amyloids: past, present and future.

Authors:  Pu Chun Ke; Ruhong Zhou; Louise C Serpell; Roland Riek; Tuomas P J Knowles; Hilal A Lashuel; Ehud Gazit; Ian W Hamley; Thomas P Davis; Marcus Fändrich; Daniel Erik Otzen; Matthew R Chapman; Christopher M Dobson; David S Eisenberg; Raffaele Mezzenga
Journal:  Chem Soc Rev       Date:  2020-07-07       Impact factor: 54.564

9.  Ring-like N-fold Models of Aβ42 fibrils.

Authors:  Wenhui Xi; Ulrich H E Hansmann
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

10.  Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.

Authors:  James W Larrick; Mark R Alfenito; Jamie K Scott; Paul W H I Parren; Dennis R Burton; Andrew R M Bradbury; Cynthia A Lemere; Anne Messer; James S Huston; Paul J Carter; Trudi Veldman; Kerry A Chester; Janine Schuurman; Gregory P Adams; Janice M Reichert
Journal:  MAbs       Date:  2016-08-24       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.